<?xml version="1.0" encoding="UTF-8"?>
<p>Favipiravir was also reported to have antiviral effect on Lassa fever virus, providing 100% protection in the lethal NHP model of Lassa fever.
 <xref rid="psp412510-bib-0076" ref-type="ref">
  <sup>76</sup>
 </xref> It could be an alternative to ribavirin, the only recommended drug against Lassa, or be used in combination to it. Indeed. several 
 <italic>in vitro</italic> studies and mice studies showed that ribavirin may potentiate the efficacy of favipiravir against various RNA viruses,
 <xref rid="psp412510-bib-0009" ref-type="ref">
  <sup>9</sup>
 </xref>, 
 <xref rid="psp412510-bib-0077" ref-type="ref">
  <sup>77</sup>
 </xref> which prompted its use to treat several patients with severe Lassa fever virus infection.
 <xref rid="psp412510-bib-0078" ref-type="ref">
  <sup>78</sup>
 </xref> In order to better understand how ribavirin may potentiate the efficacy of favipiravir in mice, we re‚Äêanalyzed data obtained in mice treated at different doses of favipiravir and/or ribavirin
 <xref rid="psp412510-bib-0009" ref-type="ref">
  <sup>9</sup>
 </xref> to decipher the mechanism of action of ribavirin.
</p>
